Author(s): ,
Pavla Koralkova
Department of Biology,Faculty of Medicine and Dentistry, Palacky University Olomouc,Olomouc,Czech Republic
Renata Mojzikova
Department of Biology,Faculty of Medicine and Dentistry, Palacky University Olomouc,Olomouc,Czech Republic
Pavel Timr
Department of Pediatrics,Hospital ?eské Bud?jovice,?eské Bud?jovice,Czech Republic
Joan Lluis Vives Corrons
University Hospital Clínic de Barcelona,Barcelona,Spain
Christine Macartney
Royal Belfast Hospital for Sick Children,Belfast,United Kingdom
Vladimir Divoky
Department of Biology,Faculty of Medicine and Dentistry, Palacky University Olomouc,Olomouc,Czech Republic
Richard van Wijk
Department of Clinical Chemistry and Haematology,University Medical Center Utrecht,Utrecht,Netherlands
EHA Learning Center. Koralkova P. Jun 12, 2015; 100611
Disclosure(s): Faculty of Medicine and Dentistry, Palacky University, Olomouc
Department of Biology
Pavla Koralkova
Pavla Koralkova

Access to EHA Members only content is an EHA membership benefit. Click here to join EHA or renew your membership here.

Discussion Forum (0)
Rate & Comment (0)
Abstract: P371

Type: Poster Presentation

Presentation during EHA20: From 12.06.2015 17:15 to 12.06.2015 18:45

Location: Poster area (Hall C)


Hexokinase (HK) deficiency is a very rare cause of hereditary nonspherocytic hemolytic anemia (HNSHA). Hexokinase is one of the key regulatory enzymes of glycolysis, on which the red blood cell is totally dependent the production of ATP. Deficiency of HK disrupts cellular metabolism, which ultimately results in HNSHA. To date, 24 cases of hexokinase deficiency have been described. Only four of them have been characterized on the DNA level. We here describe five new cases and 3 novel mutations in HK1.


Characterize a genetic defect in patients who were found to be HK-deficient by spectrophotometrically determined red blood cell HK and pyruvate kinase (PK) enzymatic activities.


PK/HK ratio was applied to evaluate the effect of age-related increases in enzymatic activity. To confirm the diagnosis, DNA sequence analysis of HK1 was performed by Sanger sequencing. Novel mutations were characterized by biochemical methods (Km for glucose and Mg.ATP, pH stability and thermolability) and molecular studies (RT-PCR, quantitative RT-PCR, and Western Blot analysis on ex vivo cultured patient erythroblasts).


DNA sequence analysis of HK1 of 5 patients with suspected HK deficiency revealed a total of 5 different mutations in HK1. Three of them were novel (Table, novel mutations in bold). In silico analysis of mutations p.His868Tyr and p.Thr601Met by Polyphen-2 and SIFT predict that both substitutions are not tolerated. Both are located in the catalytic region, and kinetic properties are likely to be impaired upon mutation. Kinetic studies of the p.His868Tyr HK mutant showed that its affinity for ATP was indeed markedly decreased (3.2-times), whereas the affinity for glucose was slightly increased (Table). The molecular effects of the novel splice site mutation c.876-2A>G in intron 7 was studied on mRNA isolated from ex vivo cultured erythroblasts from the patient’s father, who was heterozygous for this mutation. RT-PCR analysis showed the presence of normal as well as two aberrant mRNAs species.  The aberrantly spliced transcripts lacked either exon 8 or both exons 8 and 9. Quantitative RT-PCR analysis showed that expression levels of the normally spliced mRNA variant were down-regulated 3-times compared to normal. These findings were confirmed on the protein level by Western blot analysis of HK from nucleated erythroid cells (Figure).


We report 5 mutations in HK1 in 4 unrelated families. Three of them, c.876-2A>G, Thr601Met, and p.His868Tyr have not been previously reported. The pathogenic nature of novel mutations was confirmed by molecular and biochemical studies. Our results contribute to a better understanding of the genotype-to-phenotype correlation of HK deficiency, a very rare enzyme disorder of the red blood cell. Supported by Ministry of Health of Czech Republic, grant NT/13587 and IGA_LF_2015_015.

Keyword(s): Hemolytic anemia, Red blood cell

Session topic: Red blood cells and iron - Biology
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.

Save Settings